11,400 Shares in GRAIL, Inc. $GRAL Purchased by Trifecta Capital Advisors LLC

Key Points

• Trifecta Capital Advisors LLC acquired 11,400 shares of GRAIL, Inc. valued at approximately $586,000, marking a new stake in the second quarter.
• Insider selling was noted, with CFO Aaron Freidin and President Joshua J. Ofman selling 8,000 and 81,385 shares respectively, leading to a 2.72% and 17.02% decrease in their holdings.
• GRAIL's stock had a significant increase of 15.9% recently, with a current price nearing $72.79 and a 52-week high of $73.74.

Trifecta Capital Advisors LLC bought a new stake in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,400 shares of the company's stock, valued at approximately $586,000.

A number of other institutional investors and hedge funds have also made changes to their positions in GRAL. Caldwell Sutter Capital Inc. bought a new position in shares of GRAIL during the first quarter valued at approximately $28,000. KBC Group NV increased its stake in shares of GRAIL by 187.7% during the first quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after purchasing an additional 933 shares in the last quarter. S.A. Mason LLC increased its stake in shares of GRAIL by 50.1% during the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after purchasing an additional 500 shares in the last quarter. Farther Finance Advisors LLC increased its stake in shares of GRAIL by 768.1% during the second quarter. Farther Finance Advisors LLC now owns 816 shares of the company's stock valued at $42,000 after purchasing an additional 722 shares in the last quarter. Finally, NewEdge Advisors LLC increased its stake in shares of GRAIL by 390.3% during the first quarter. NewEdge Advisors LLC now owns 1,760 shares of the company's stock valued at $45,000 after purchasing an additional 1,401 shares in the last quarter.

Insider Activity

In other GRAIL news, CFO Aaron Freidin sold 8,000 shares of the business's stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total transaction of $311,440.00. Following the completion of the sale, the chief financial officer directly owned 286,020 shares in the company, valued at $11,134,758.60. The trade was a 2.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Joshua J. Ofman sold 81,385 shares of the stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $62.50, for a total transaction of $5,086,562.50. Following the completion of the transaction, the president owned 396,797 shares in the company, valued at $24,799,812.50. This trade represents a 17.02% decrease in their position. The disclosure for this sale can be found here. Insiders sold 103,279 shares of company stock worth $6,152,839 over the last three months. Insiders own 1.85% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on GRAL shares. UBS Group set a $75.00 target price on shares of GRAIL in a research note on Friday, October 3rd. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of GRAIL in a research note on Wednesday. Finally, Canaccord Genuity Group increased their price target on shares of GRAIL from $43.00 to $75.00 and gave the company a "buy" rating in a report on Friday, October 3rd. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $56.67.

GRAIL Stock Up 15.9%

NASDAQ:GRAL opened at $72.79 on Thursday. The company's 50 day moving average price is $40.51 and its 200-day moving average price is $37.89. GRAIL, Inc. has a 52 week low of $12.57 and a 52 week high of $73.74. The stock has a market cap of $2.62 billion, a price-to-earnings ratio of -5.55 and a beta of 4.11.

GRAIL (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). The company had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. As a group, sell-side analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRAIL, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.